chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX261023P00011500
IBRX Oct 23 2026 11.50 Put
optionOPRA

EODOct 14, 2026
2.67USD7Vol6OI
Loading…
Underlying
IBRX
Underlying Price
$8.34
Type
Put
Strike
11.5
Expiration
Oct 23, 2026
DTE
3d
Moneyness
ITM
Intrinsic
$3.16
IBRX 11.5 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Oct 23, 20263d$2.67+0.00%76
Oct 30, 202610d$1.98+30.26%56
Nov 6, 202617d——00
Nov 13, 202624d$2.02-4.72%15
Nov 27, 202638d——00
IBRX Nearby Strikes · Oct 23, 2026
StrikeLastChangeVolOpen IntMoneyness
8.5 P$0.11+22.22%5355ITM
9 P$0.37+48.00%175878ITM
9.5 P$0.55+83.33%76438ITM
10 P$0.93+78.85%1761,656ITM
10.5 P$0.89+18.67%1238ITM
11 P$2.18+190.67%218ITM
11.5 P$2.67+0.00%76ITM
12 P——00ITM
12.5 P$2.66+5.98%1028ITM
13 P——00ITM
13.5 P——00ITM
14 P——01ITM
14.5 P——01ITM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.